IDx-DR

Digital Diagnostics’s first FDA-cleared product is the AI diagnostic platform Dr. Michael Abramoff had envisioned years earlier. The platform, called IDx-DR, detects diabetic retinopathy and macular edema in primary care. After completing a rigorous prospective, preregistered clinical trial at primary care sites across the country, IDx-DR became the first FDA-cleared AI diagnostic system to make a diagnosis without physician input.